Oral Anticoagulant Initiation: Rationale for the Use of Warfarin Dosing Nomograms

Oral anticoagulants prevent thrombosis however they are associated with bleeding. The risk of both bleeding and thrombosis is increased when the International Normalized Ratio (INR) is outside the desired therapeutic range. Hence, oral anticoagulants should be administered with the intention of maximizing the "time within the therapeutic range." The frequency of INR values outside this range can be decreased by (1) warfarin initiation algorithms that guide initial therapy and (2) use of computerized systems to guide chronic warfarin therapy. This article reviews these techniques.

[1]  D. Anderson,et al.  Comparison of 10-mg and 5-mg Warfarin Initiation Nomograms Together with Low-Molecular-Weight Heparin for Outpatient Treatment of Acute Venous Thromboembolism , 2003, Annals of Internal Medicine.

[2]  M. Prins,et al.  Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison , 2000, The Lancet.

[3]  W. Ageno,et al.  Exaggerated initial response to warfarin following heart valve replacement. , 1999, The American journal of cardiology.

[4]  J. Hirsh,et al.  A randomized trial comparing 5-mg and 10-mg warfarin loading doses. , 1999, Archives of internal medicine.

[5]  J. Jespersen,et al.  Multicentre randomised study of computerised anticoagulant dosage , 1998, The Lancet.

[6]  W. Ageno,et al.  A randomized comparison of a computer-based dosing program with a manual system to monitor oral anticoagulant therapy. , 1998, Thrombosis research.

[7]  M. Kovacs,et al.  Randomized Assessment of a Warfarin Nomogram for Initial Oral Anticoagulation after Venous Thromboembolic Disease , 1998, Pathophysiology of Haemostasis and Thrombosis.

[8]  F. Verheugt,et al.  A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin , 1997, Annals of neurology.

[9]  J. Hirsh,et al.  Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy , 1997, Annals of Internal Medicine.

[10]  W. J. Hamilton,et al.  Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial , 1996, The Lancet.

[11]  J. Vandenbroucke,et al.  Optimal oral anticoagulant therapy in patients with mechanical heart valves. , 1995, The New England journal of medicine.

[12]  G. Albers,et al.  Atrial fibrillation and stroke. Three new studies, three remaining questions. , 1994, Archives of internal medicine.

[13]  E. Hylek,et al.  Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin , 1994, Annals of Internal Medicine.

[14]  L. Poller,et al.  Prospective comparative study of computer programs used for management of warfarin. , 1993, Journal of clinical pathology.

[15]  P. J. Ryan,et al.  Computer control of anticoagulant dose for therapeutic management. , 1989, BMJ.

[16]  P. Wyld,et al.  Computer dosing in anticoagulant clinics--the way forward? , 1988, Clinical and laboratory haematology.

[17]  R Wilson,et al.  Computer assisted management of warfarin treatment. , 1984, British medical journal.

[18]  J. Hirsh,et al.  Managing oral anticoagulant therapy. , 2001, Chest.

[19]  J. Hirsh,et al.  Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. , 2001, Chest.

[20]  K. Hampton,et al.  A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients. , 2000, Age and ageing.

[21]  J Jespersen,et al.  Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation. , 1998, Lancet.

[22]  Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group. , 1994, Lancet.